We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
876
DELISTED
Apellis Pharmaceuticals
APLS
| $917K | ﹤0.01% |
23,900
+1,500
| +7% | +$67.9K |
|
877
Denali Therapeutics
DNLI
$3.97B
| $917K | ﹤0.01% |
39,500
+15,600
| +65% | +$300K |
|
878
Assured Guaranty
AGO
$3.35B
| $911K | ﹤0.01% |
11,804
-100
| -0.8% | -$7.82K |
|
879
Franklin Electric
FELE
$4.68B
| $908K | ﹤0.01% |
9,423
+2,000
| +27% | +$199K |
|
880
Power Integrations
POWI
$3.48B
| $906K | ﹤0.01% |
12,902
+3,400
| +36% | +$244K |
|
881
Dycom Industries
DY
$12.3B
| $903K | ﹤0.01% |
5,351
| – | – |
|
882
Neogen
NEOG
$2.59B
| $901K | ﹤0.01% |
57,664
| – | – |
|
883
Rush Enterprises Class A
RUSHA
$9.62B
| $898K | ﹤0.01% |
21,439
-1,300
| -6% | -$59.7K |
|
884
United Bankshares
UBSI
$6.68B
| $897K | ﹤0.01% |
27,646
+5,500
| +25% | +$182K |
|
|
CSW
885
CSW Industrials
CSW
$5.59B
| $894K | ﹤0.01% |
3,369
| – | – |
|
886
Champion Homes
SKY
$5.23B
| $894K | ﹤0.01% |
13,200
| – | – |
|
887
Boot Barn
BOOT
$4.92B
| $890K | ﹤0.01% |
6,900
+900
| +15% | +$101K |
|
888
CBIZ
CBZ
$2.96B
| $889K | ﹤0.01% |
12,000
-300
| -2% | -$22.7K |
|
889
Littelfuse
LFUS
$11.4B
| $886K | ﹤0.01% |
3,465
| – | – |
|
890
Glacier Bancorp
GBCI
$6.48B
| $884K | ﹤0.01% |
23,674
| – | – |
|
891
Mueller Water Products
MWA
$3.98B
| $884K | ﹤0.01% |
49,336
+9,800
| +25% | +$169K |
|
892
FirstCash
FCFS
$9.14B
| $883K | ﹤0.01% |
8,416
| – | – |
|
|
MZTI
893
The Marzetti Company
MZTI
$3.22B
| $883K | ﹤0.01% |
4,672
+1,200
| +35% | +$229K |
|
894
AppFolio
APPF
$7.22B
| $880K | ﹤0.01% |
3,600
| – | – |
|
895
Silgan Holdings
SLGN
$4.46B
| $880K | ﹤0.01% |
20,788
| – | – |
|
896
National Health Investors
NHI
$3.5B
| $877K | ﹤0.01% |
12,951
| – | – |
|
897
Ultragenyx Pharmaceutical
RARE
$2.6B
| $876K | ﹤0.01% |
21,323
+6,700
| +46% | +$286K |
|
898
SL Green Realty
SLG
$4.08B
| $876K | ﹤0.01% |
15,465
+1,300
| +9% | +$68.5K |
|
899
Piper Sandler
PIPR
$5.54B
| $868K | ﹤0.01% |
15,088
| – | – |
|
900
LivaNova
LIVN
$4.53B
| $863K | ﹤0.01% |
15,737
-300
| -2% | -$17.1K |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.